At the end of November, Pfizer stands to lose a $10-billion-a-year revenue stream when the patent on its cholesterol lowering drug Lipitor expires and cheaper generics begin to cut into the company’s huge sales. If people only knew they were being brain washed about taking this and other drugs related to chronic diseases.
Posts tagged as:
